1. |
Inoue Y,Trapnell BC,Tazawa R,et al.Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.Am J Respir Crit Care Med,2008,177:752-762.
|
2. |
Trapnell BC,Whitsett JA,Nakata K.Pulmonary alveolar proteinosis.N Engl J Med,2003,349:2527-2539.
|
3. |
Kitamura T,Uchida K,Tanaka N,et al.Serological diagnosis of idiopathic pulmonary alveolar proteinosis.Am J Respir Crit Care Med,2000,162:658-662.
|
4. |
Lin FC,Chang GD,Chern MS,et al.Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis,Thorax,2006,61:528-534.
|
5. |
Ishii H,Tazawa R,Kaneko C,et al.Clinical features of secondary pulmonary alveolar proteinosis:pre-mortem cases in Japan.Eur Respir J,2011,37:465-468.
|
6. |
Lee KN,Levin DL,Webb WR,et al.Pulmonary alveolar proteinosis:high-resolution CT,chest radiographic,and functional correlations.Chest,1997,111:989-995.
|
7. |
Uchida K,Nakata K,Carey B,et al.Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis.J Immunol Methods,2014,402:57-70.
|
8. |
Holbert JM,Costello P,Li W,et al.CT features of pulmonary alveolar proteinosis.AJR Am J Roentgenol,2001,176:1287-1294.
|
9. |
Seymour JF,Presneill JJ.Pulmonary alveolar proteinosis.progress in the first 44 years.Am J Respir Crit Care Med,2002,166:215-235.
|
10. |
Arai T,Inoue Y,Sugimoto C,et al.CYFRA 21-1 as a disease severity marker for autoimmune pulmonary alveolar proteinosis.Respirology,2014,19:246-252.
|
11. |
Bonella F,Bauer PC,Griese M,et al.Pulmonary alveolar proteinosis:New insights from a single-center cohort of 70 patients.Respir Med,2011,105:1908-1916.
|
12. |
Cummings KJ,Donat WE,Ettensohn DB,et al.Pulmonary alveolar proteinosis in workers at an indium processing facility.Am J Respir Crit Care Med,2010,181:458-464.
|